111 related articles for article (PubMed ID: 23149922)
1. MIG-7 controls COX-2/PGE2-mediated lung cancer metastasis.
Ho MY; Liang SM; Hung SW; Liang CM
Cancer Res; 2013 Jan; 73(1):439-49. PubMed ID: 23149922
[TBL] [Abstract][Full Text] [Related]
2. MIG-7 and phosphorylated prohibitin coordinately regulate lung cancer invasion/metastasis.
Ho MY; Liang CM; Liang SM
Oncotarget; 2015 Jan; 6(1):381-93. PubMed ID: 25575814
[TBL] [Abstract][Full Text] [Related]
3. Recombinant viral capsid protein VP1 suppresses lung cancer metastasis by inhibiting COX-2/PGE2 and MIG-7.
Ho MY; Hung SW; Liang CM; Liang SM
Oncotarget; 2014 Jun; 5(11):3931-43. PubMed ID: 25004182
[TBL] [Abstract][Full Text] [Related]
4. Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE
Che D; Zhang S; Jing Z; Shang L; Jin S; Liu F; Shen J; Li Y; Hu J; Meng Q; Yu Y
Mol Immunol; 2017 Oct; 90():197-210. PubMed ID: 28837884
[TBL] [Abstract][Full Text] [Related]
5. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
[TBL] [Abstract][Full Text] [Related]
6. Lithium Chloride Increases COX-2 Expression and PGE2 Production in a Human Granulosa-Lutein SVOG Cell Line Via a GSK-3β/β-Catenin Signaling Pathway.
Bai L; Chang HM; Cheng JC; Chu G; Leung PCK; Yang G
Endocrinology; 2017 Sep; 158(9):2813-2825. PubMed ID: 28911173
[TBL] [Abstract][Full Text] [Related]
7. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
Geng F; Jiang Z; Song X; Zhou H; Zhao H
Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of the S1P
Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
[TBL] [Abstract][Full Text] [Related]
9. PROSTAGLANDIN E
Madrigal-Martínez A; Constâncio V; Lucio-Cazaña FJ; Fernández-Martínez AB
J Cell Physiol; 2019 May; 234(5):7548-7559. PubMed ID: 30367494
[TBL] [Abstract][Full Text] [Related]
10. Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation.
Hsu HH; Chen MC; Day CH; Lin YM; Li SY; Tu CC; Padma VV; Shih HN; Kuo WW; Huang CY
World J Gastroenterol; 2017 Feb; 23(7):1171-1179. PubMed ID: 28275297
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of tumor suppressing STF cDNA 3 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by the Wnt/GSK-3β/β-catenin/Snail signaling pathway.
Lv YF; Dai H; Yan GN; Meng G; Zhang X; Guo QN
Cancer Lett; 2016 Apr; 373(2):164-73. PubMed ID: 26845447
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion.
Zheng H; Li Y; Wang Y; Zhao H; Zhang J; Chai H; Tang T; Yue J; Guo AM; Yang J
Toxicol Appl Pharmacol; 2014 Oct; 280(1):10-20. PubMed ID: 25094029
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib potentially inhibits metastasis of lung cancer promoted by surgery in mice, via suppression of the PGE2-modulated β-catenin pathway.
Zhang S; Da L; Yang X; Feng D; Yin R; Li M; Zhang Z; Jiang F; Xu L
Toxicol Lett; 2014 Mar; 225(2):201-7. PubMed ID: 24374173
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids.
Lim K; Han C; Xu L; Isse K; Demetris AJ; Wu T
Cancer Res; 2008 Jan; 68(2):553-60. PubMed ID: 18199552
[TBL] [Abstract][Full Text] [Related]
15. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
[TBL] [Abstract][Full Text] [Related]
16. PGE
Lin MC; Chen SY; He PL; Herschman H; Li HJ
Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
[TBL] [Abstract][Full Text] [Related]
17. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.
Qin G; Xu F; Qin T; Zheng Q; Shi D; Xia W; Tian Y; Tang Y; Wang J; Xiao X; Deng W; Wang S
Oncotarget; 2015 Dec; 6(39):41794-808. PubMed ID: 26540629
[TBL] [Abstract][Full Text] [Related]
18. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.
Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC
Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of C-C chemokine receptor type 7 expression by membrane-associated prostaglandin E synthase-1/prostaglandin E2 requires glycogen synthase kinase 3β-mediated signal transduction in colon cancer cells.
Yu S; Hou Q; Sun H; Liu J; Li J
Mol Med Rep; 2015 Nov; 12(5):7169-75. PubMed ID: 26352871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
